SCHEMBL13700136

SCHEMBL13700136

COc1ccc2c(NC(=O)c3ccc(CSc4ccc(F)cc4)cc3)c(C(N)=O)oc2c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.53
TP53 P04637 11/20 0.53
MAPK10 P53779 3/20 0.53
TSHR P16473 2/20 0.53
HSD17B10 Q99714 2/20 0.53
AHR P35869 1/20 0.53
RXFP1 Q9HBX9 4/20 0.52
HPGD P15428 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
HDAC3 O15379 1/20 0.48
NCOR1 O75376 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
LMNA P02545 1/20 0.48
ALOX15 P16050 1/20 0.48
ABL1 P00519 1/20 0.47
SRC P12931 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4252550 0.89 MAPT (0.66) MAPTTP53MAPK10TSHRHSD17B10
SCHEMBL13700143 0.89 MAPT (0.49) MAPTTP53MAPK10TSHRHSD17B10
SCHEMBL13699727 0.85 MAPT (0.60) MAPTTP53MAPK10TSHRHSD17B10
SCHEMBL13699759 0.83 HSD17B10 (0.67) MAPTTP53MAPK10TSHRHSD17B10
SCHEMBL13699745 0.82 HSD17B10 (0.59) MAPTTP53MAPK10TSHRHSD17B10
SCHEMBL13700135 0.81 HDAC1 (0.49) MAPTTP53MAPK10TSHRHSD17B10
SCHEMBL13699732 0.81 MAPT (0.58) MAPTTP53MAPK10TSHRHSD17B10
SCHEMBL4255762 0.81 SMN1; SMN2 (0.52) MAPTTP53MAPK10TSHRHSD17B10
SCHEMBL13699729 0.80 HSD17B10 (0.63) MAPTTP53MAPK10TSHRHSD17B10
SCHEMBL13699715 0.79 HSD17B10 (0.62) MAPTTP53MAPK10TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F MAPT 4025/4885TP53 4721/4885MAPK10 3802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.